Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Les L. Noe
Observed names:
L NOE,
L Noe,
L. L. Noe,
L. Noe,
Les Noe,
Leslie Lyle Noe
show all 6
Institution:
AbbVie (United States)
Observed institutions:
AbbVie (United States),
ICON PLC (Ireland)
OpenAlex ID:
A5109246280
Reimbursement and economic factors influencing dialysis modality choice around the world
2008
·
P. M. Just
, F. Th. de Charro
, et al.
·
Nephrology Dialysis Transplantation
·
155
PDF
Economic evaluations of dialysis treatment modalities
2008
·
Paul Michael Just
, Miguel Carlos Riella
, et al.
·
Health Policy
·
105
Medication Adherence in Chronic Disease: Issues in Posttransplant Immunosuppression
2007
·
R. Hansen
, R. Seifeldin
, et al.
·
Transplantation Proceedings
·
102
A Pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure
1999
·
Les L. Noe
, Mary Glenn Vreeland
, et al.
·
Clinical Therapeutics
·
58
Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER
2008
·
Norman Zinner
, Les Noe
, et al.
·
Current Medical Research and Opinion
·
27
The implications of poor medication persistence with treatment for overactive bladder.
2004
·
Les Noe
, Robyn Sneeringer
, et al.
·
PubMed
·
27
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: A 2-week, multicenter, randomized, open-label study
2008
·
J DONOHUE
, N HANANIA
, et al.
·
Clinical Therapeutics
·
22
A Pharmacoeconomic Model Comparing Two Long-Acting Treatments for Overactive Bladder
2002
·
Les Noe
, Russell Becker
, et al.
·
Journal of Managed Care Pharmacy
·
22
Pmh10: Health Outcomes of Childhood Attention-deficit/hyperactivity Disorder (adhd): Health Care Use and Work Status of Caregivers
2001
·
L Noe
, CS Hankin
·
Value in Health
·
18
Economic evaluations of peritoneal dialysis and hemodialysis: 2004-2012
2013
·
Frank Xiaoqing Liu
, Tiffany P. Quock
, et al.
·
F1000Research
·
17
Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain
2013
·
Sanjay Merchant
, Les L. Noe
, et al.
·
Clinical Therapeutics
·
17
Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: An exploratory subgroup analysis
2009
·
Norman Zinner
, Les Noe
, et al.
·
The American Journal of Geriatric Pharmacotherapy
·
12
Qolp-20. Impact of Glioblastoma on Patient-reported Symptom Burden and Physical Activity Assessed by Conventional Instruments and a Novel Device–based Technology
2019
·
Terri Armstrong
, Vinay Puduvalli
, et al.
·
Neuro-Oncology
·
2
PDF
Qolp-31. Assessing the Impact of Glioblastoma on Work Productivity in Patients and Their Caregivers
2019
·
Terri Armstrong
, Vinay Puduvalli
, et al.
·
Neuro-Oncology
PDF
Peritoneal dialysis vs. in-center hemodialysis: a systematic review of the economic literature
2012
·
Frank Xiaoqing Liu
, Tiffany P. Quock
, et al.
·
F1000Research
PSY12 A Budget Impact Analysis of Tapentadol Extended Release (ER) for the Treatment of Moderate to Severe Chronic Pain
2012
·
S. Merchant
, L. Noe
, et al.
·
Value in Health
Pcv66 Inpatient Resource Use Among Patients Treated for Primary Atrial Fibrillation (af): Role of Clinical Factors and Choice of Initial Conversion Therapy
2009
·
J Spalding
, A Exuzides
, et al.
·
Value in Health
PDF
Paa7 Pharmacoeconomic Outcomes of Levalbuterol and Racemic Albuterol in Hospitalized Patients Requiring Nebulization Therapy (polaris)
2007
·
R Claus
, L Noe
, et al.
·
Value in Health
PDF
Paa8 Quality-adjusted Length of Stay Analysis of Hospitalized Patients With Asthma or Copd Treated With Levalbuterol or Racemic Albuterol
2007
·
D Pasta
, S Silva
, et al.
·
Value in Health
Pmh20: Medical Resources Consumption by Patients With Chronic and Breakthrough Pain
2000
·
L Noe
, P Peeples
·
Value in Health
PDF
Show more works
View as search
Works count:
20
Citation count:
584
H-index:
12
I10-index:
12
Year
Topic
Type
